SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0000078003-18-000083
Filing Date
2018-10-22
Accepted
2018-10-22 16:30:58
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D sch13d_allo.htm SC 13D 115510
  Complete submission text file 0000078003-18-000083.txt   117097
Mailing Address 235 E 42ND ST NEW YORK NY 10017
Business Address 235 E 42ND ST NEW YORK NY 10017 2125732323
PFIZER INC (Filed by) CIK: 0000078003 (see all company filings)

IRS No.: 135315170 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D
SIC: 2834 Pharmaceutical Preparations

Mailing Address 210 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 210 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080 (650) 457-2700
Allogene Therapeutics, Inc. (Subject) CIK: 0001737287 (see all company filings)

IRS No.: 823562771 | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-90685 | Film No.: 181132554
SIC: 2836 Biological Products, (No Diagnostic Substances)